Pulse Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Pulse Biosciences's estimated annual revenue is currently $39.9M per year.
- Pulse Biosciences's estimated revenue per employee is $407,235
- Pulse Biosciences's total funding is $168.3M.
Employee Data
- Pulse Biosciences has 98 Employees.
- Pulse Biosciences grew their employee count by 32% last year.
Pulse Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Engineering | Reveal Email/Phone |
2 | Chief Science Officer, Cardiac Surgery | Reveal Email/Phone |
3 | Chief Technology Officer & Director | Reveal Email/Phone |
4 | VP, Finance | Reveal Email/Phone |
5 | VP Operations | Reveal Email/Phone |
6 | VP, Regulatory, Clinical & Quality Affairs | Reveal Email/Phone |
7 | General Counsel | Reveal Email/Phone |
8 | Director Product Management | Reveal Email/Phone |
9 | Senior Director Supply Chain & Logistics | Reveal Email/Phone |
10 | Director R&D & Mechanical Engineering, New Application Development | Reveal Email/Phone |
Pulse Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 55 | -17% | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Pulse Biosciences?
Pulse Biosciences (NASDAQ:PLSE) is a medical technology company developing a therapeutic tissue treatment platform based on Nano-Pulse Electro-Signaling, a proprietary bioelectronics cell signaling technology. Published pre-clinical studies have shown that a single, brief exposure of Nano-Pulse Electro-Signaling to target tissue initiates a cascade of events within cells and in the surrounding microenvironment that results in apoptosis (cell death) and the priming of a durable adaptive immune response. Pulse Biosciences is pursuing a variety of applications for its technology that exploits the technology’s unique biologic effect in immuno-oncology, dermatology, aesthetics, and veterinary medicine. Clinical studies are being planned using the first commercial system designed to support a broad array of electrodes for use in superficial, minimally-invasive, and open surgical procedures.
keywords:N/A
$168.3M
Total Funding
98
Number of Employees
$39.9M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pulse Biosciences News
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life...
Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022...
(Nasdaq: PLSE) (the Company or Pulse Biosciences), a novel bioelectric medicine company, today announced that the Company's Board of...
Other Companies in Hayward
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.4M | 98 | 9% | N/A |
#2 | $14.5M | 100 | -12% | $27.2M |
#3 | $32.8M | 100 | -7% | N/A |
#4 | $25.6M | 102 | 7% | N/A |
#5 | $14.8M | 102 | 15% | N/A |